FDA Strengthens Compounding Safety with Cesium Ban And Research Collaboration

FDA has taken additional steps to make drug compounding safer for patients, including a ban on cesium chloride because of “significant safety risks” it poses and a pair of university research collaborations to help further develop a list of bulk drug ingredients that can be safely compounded.

Pharmacistswithmortatandpestle_1200x675

FDA intends to take enforcement action against drug compounding pharmacies that use cesium chloride in compounded drugs, and has agreed to list it with bulk drug ingredients that are too risky for patients. The agency’s action is in response to a citizen petition requesting such a ban for safety reasons.

The agency also announced on July 23 two new research collaborations with several universities to help develop a list...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance